The World Health Organisation (WHO) has issued a medical product alert on falsified semaglutides, the type of medicines that are used for the treatment of type 2 diabetes and obesity in some countries.
Trending
- CISLAC applauds Supreme Court for upholding EFCC’s authority
- YouthWASH urges prioritisation of toilets, sanitation
- Lassa fever: Physician emphasises improved household, community hygiene
- Foreign coys to partner NADF on cassava industrialisation in Nigeria
- Constant sexual intercourse doesn’t prevent prostate cancer– urologist
- Experts demand urgent action on adolescent health
- Floods hit Northern Philippines after Typhoon forces dam release
- CS-SUNN sounds alarm on rising malnutrition in Kaduna
